EUVIMEDEUVIMED entdecken
Open Access

A Comparative Review of Irish and Australian Expert Consensus on Criteria for Initiating and Continuing Reimbursed Janus Kinase Inhibitor Therapy in Alopecia Areata Patients

Aoife Boyle iD, John Bourke, Nicola Cooke, Mary Laing, Chantal Louise Cotter, Cathal O'Connor, Donna Cummins, Donal O'Kane, Caitriona Ryan, Alan D Irvine, Ian McDonald, Meryl Thomas iD und 6 weitere

Skin Appendage Disorders · 07.10.2026 · 1-1

DOI: 10.1159/sad/aesag017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Appendage Disorders, online erschienen am 07.10.2026. Verfasst von Aoife Boyle und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Galway, Galway, Ireland. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Janus kinase inhibitors (JAKis) are a multi-jurisdiction approved treatment for alopecia areata (AA). Despite obtaining the highest level of evidence of efficacy among available therapies, and carrying the strongest recommendations from international expert groups, access in Ireland, as in other countries such as Australia, has been restricted due to reimbursement challenges. This study replicates research conducted in Australia, which aimed to establish expert consensus on criteria for initiating and continuing reimbursed JAKis for AA. By comparing Irish and Australian findings, we aimed to provide a broader international perspective on the utility and need for reimbursed JAKis in the management of AA.

Methods

A modified version of an eDelphi study developed by Australasian colleagues was developed with input from 12 Irish dermatologists with an interest in hair and scalp disorders to reflect an Irish perspective. The finalized survey, comprising 43 questions, was distributed electronically to members of the Irish Association of Dermatologists for participation. Consensus was defined as ≥75% agreement or disagreement.

Results

Sixteen consultant dermatologists completed the survey. All agreed that JAK inhibitors are the preferred systemic treatment for patients with SALT scores >50. Several additional factors were deemed significant when assessing eligibility for JAKis, namely, refractory disease, psychosocial morbidity, rapid progression, impaired quality of life, disease relapse, ophiasis pattern, and poorly camouflaged hair loss. These findings closely mirrored the Australian consensus. Most experts also agreed that JAKi therapy should be re-evaluated at 12 months with treatment failure defined as

Schlagwörter

Stichwörter der Autor:innen

Alopecia areataExpert guidelinesJanus kinase inhibitorsReimbursement

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Galway, Galway, Ireland.
  • Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
  • Department of Dermatology, Ulster Hospital, Belfast, UK.
  • School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Department of Dermatology, Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Department of Dermatology, Beaumont Hospital, Dublin, Ireland.

ORCID-Profile: Aoife Boyle, Meryl Thomas, John Frewen

Zitieren

APA

Boyle, A., Bourke, J., Cooke, N., Laing, M., Cotter, C. L., O'Connor, C., Cummins, D., O'Kane, D., Ryan, C., Irvine, A. D., McDonald, I., Thomas, M., Hankins, M., Bokhari, L., Eisman, S., Frewen, J., Sinclair, R., & Wall, D. (2026). A Comparative Review of Irish and Australian Expert Consensus on Criteria for Initiating and Continuing Reimbursed Janus Kinase Inhibitor Therapy in Alopecia Areata Patients. Skin Appendage Disorders, 1-1. https://doi.org/10.1159/sad/aesag017

Vancouver

Boyle A, Bourke J, Cooke N, Laing M, Cotter CL, O'Connor C, et al. A Comparative Review of Irish and Australian Expert Consensus on Criteria for Initiating and Continuing Reimbursed Janus Kinase Inhibitor Therapy in Alopecia Areata Patients. Skin Appendage Disorders. 2026:1-1. doi:10.1159/sad/aesag017

BibTeX
@article{Boyle2026,
  author = {Boyle, Aoife and Bourke, John and Cooke, Nicola and Laing, Mary and Cotter, Chantal Louise and O'Connor, Cathal and Cummins, Donna and O'Kane, Donal and Ryan, Caitriona and Irvine, Alan D and McDonald, Ian and Thomas, Meryl and Hankins, Madeline and Bokhari, Laita and Eisman, Samantha and Frewen, John and Sinclair, Rodney and Wall, Dmitri},
  title = {A Comparative Review of Irish and Australian Expert Consensus on Criteria for Initiating and Continuing Reimbursed Janus Kinase Inhibitor Therapy in Alopecia Areata Patients},
  journal = {Skin Appendage Disorders},
  year = {2026},
  pages = {1--1},
  doi = {10.1159/sad/aesag017}
}
Kostenlos starten →